In particular, Kauloniemi’s group demonstrated that miR-193b is hypermethylated in prostate cancer cells, leading to the upregulation of the target gene CCND1, which encodes for cyclin D1 [86]. The gene discussed is CCND1; the disease is prostate cancer.